UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-41641
SHL TELEMEDICINE LTD.
(Translation of registrant’s name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On May 9, 2024, SHL Telemedicine Ltd. (the “Company”) announced that at the Special General Meeting of Shareholders of the Company held on May 9, 2024 (the “Meeting”), the sole proposal to approve the Company’s Compensation Policy for Executive Officers and Directors (the “Compensation Policy”) for a period of three years from the date of the Meeting was approved by the shareholders. A copy of the press release issued by the Company on May 9, 2024, and announcing the approval of the Compensation Policy is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546), and its Registration Statement on Form 20FR12B/A filed with the Securities and Exchange Commission on March 28, 2023 (File No. 001-41641).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | SHL Telemedicine Ltd. | |
| | | | |
| By: | /s/ Amir Hai
| |
| | | Amir Hai | |
| | | Chief Financial Officer | |
| | | | |
May 9, 2024
